LCO \\PRDFS1\HCOUSERS\BARRYJN\WS\2021HB-06587-R01-
HB.docx
1 of 2
General Assembly Substitute Bill No. 6587
January Session, 2021
AN ACT REQUIRING HEA LTH INSURANCE COVERA GE FOR
EPINEPHRINE CARTRIDG E INJECTORS.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
Section 1. (NEW) (Effective January 1, 2022) (a) Each individual health 1
insurance policy providing coverage of the type specified in 2
subdivisions (1), (2), (4), (11), (12) and (16) of section 38a-469 of the 3
general statutes delivered, issued for delivery, renewed, amended or 4
continued in this state on or after January 1, 2022, that includes coverage 5
for outpatient prescription drugs shall provide coverage for epinephrine 6
cartridge injectors, as defined in section 19a-909 of the general statutes. 7
(b) No policy described in subsection (a) of this section shall impose 8
a coinsurance, copayment, deductible or other out-of-pocket expense for 9
an epinephrine cartridge injector in an amount that is greater than 10
twenty-five dollars. The provisions of this subsection shall apply to a 11
high deductible health plan, as that term is used in subsection (f) of 12
section 38a-493 of the general statutes, to the maximum extent permitted 13
by federal law, except if such plan is used to establish a medical savings 14
account or an Archer MSA pursuant to Section 220 of the Internal 15
Revenue Code of 1986, or any subsequent corresponding internal 16
revenue code of the United States, as amended from time to time, or a 17
health savings account pursuant to Section 223 of said Internal Revenue 18 Substitute Bill No. 6587
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2021HB-06587-
R01-HB.docx }
2 of 3
Code, as amended from time to time, the provisions of this subsection 19
shall apply to such plan to the maximum extent that (1) is permitted by 20
federal law, and (2) does not disqualify such account for the deduction 21
allowed under said Section 220 or 223, as applicable. 22
Sec. 2. (NEW) (Effective January 1, 2022) (a) Each group health 23
insurance policy providing coverage of the type specified in 24
subdivisions (1), (2), (4), (11), (12) and (16) of section 38a-469 of the 25
general statutes delivered, issued for delivery, renewed, amended or 26
continued in this state on or after January 1, 2022, that includes coverage 27
for outpatient prescription drugs shall provide coverage for epinephrine 28
cartridge injectors, as defined in section 19a-909 of the general statutes. 29
(b) No policy described in subsection (a) of this section shall impose 30
a coinsurance, copayment, deductible or other out-of-pocket expense for 31
an epinephrine cartridge injector in an amount that is greater than 32
twenty-five dollars. The provisions of this subsection shall apply to a 33
high deductible health plan, as that term is used in subsection (f) of 34
section 38a-520 of the general statutes, to the maximum extent permitted 35
by federal law, except if such plan is used to establish a medical savings 36
account or an Archer MSA pursuant to Section 220 of the Internal 37
Revenue Code of 1986, or any subsequent corresponding internal 38
revenue code of the United States, as amended from time to time, or a 39
health savings account pursuant to Section 223 of said Internal Revenue 40
Code, as amended from time to time, the provisions of this subsection 41
shall apply to such plan to the maximum extent that (1) is permitted by 42
federal law, and (2) does not disqualify such account for the deduction 43
allowed under said Section 220 or 223, as applicable. 44
This act shall take effect as follows and shall amend the following
sections:
Section 1 January 1, 2022 New section
Sec. 2 January 1, 2022 New section
INS Joint Favorable Subst. Substitute Bill No. 6587
LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2021HB-06587-
R01-HB.docx }
3 of 3